| Attribute |
Value |
| 52 Week Change |
0.09655595 |
| Address1 |
1 Kenvue Way |
| All Time High |
27.795 |
| All Time Low |
14.02 |
| Ask |
17.75 |
| Ask Size |
26,500 |
| Audit Risk |
4 |
| Average Daily Volume10 Day |
18,950,720 |
| Average Daily Volume3 Month |
21,973,800 |
| Average Volume |
21,973,800 |
| Average Volume10Days |
18,950,720 |
| Beta |
0.447 |
| Bid |
17.7 |
| Bid Size |
16,500 |
| Board Risk |
3 |
| Book Value |
5.496 |
| City |
Summit |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
6 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
17.76 |
| Current Ratio |
1.005 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
17.93 |
| Day Low |
17.54 |
| Debt To Equity |
81.617 |
| Display Name |
Kenvue |
| Dividend Date |
1,790,899,200 |
| Dividend Rate |
0.84 |
| Dividend Yield |
4.71 |
| Earnings Call Timestamp End |
1,762,435,800 |
| Earnings Call Timestamp Start |
1,762,435,800 |
| Earnings Growth |
0.085 |
| Earnings Quarterly Growth |
0.086 |
| Earnings Timestamp |
1,786,019,400 |
| Earnings Timestamp End |
1,793,881,800 |
| Earnings Timestamp Start |
1,793,881,800 |
| Ebitda |
3,480,999,936 |
| Ebitda Margins |
0.22591999 |
| Enterprise To Ebitda |
11.955 |
| Enterprise To Revenue |
2.701 |
| Enterprise Value |
41,615,937,536 |
| Eps Current Year |
1.1823 |
| Eps Forward |
1.23981 |
| Eps Trailing Twelve Months |
0.86 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,789,948,800 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
20 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
18.4182 |
| Fifty Day Average Change |
-0.6581993 |
| Fifty Day Average Change Percent |
-0.035736356 |
| Fifty Two Week Change Percent |
9.655595 |
| Fifty Two Week High |
20.13 |
| Fifty Two Week High Change |
-2.369999 |
| Fifty Two Week High Change Percent |
-0.11773468 |
| Fifty Two Week Low |
14.02 |
| Fifty Two Week Low Change |
3.7399998 |
| Fifty Two Week Low Change Percent |
0.26676175 |
| Fifty Two Week Range |
14.02 - 20.13 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,683,207,000,000 |
| Float Shares |
1,917,988,345 |
| Forward Eps |
1.23981 |
| Forward P E |
14.324776 |
| Free Cashflow |
1,907,500,032 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
21,780 |
| Fullday Change |
-0.069999695 |
| Fullday Change Percent |
-0.39259502 |
| Fullday Price |
17.76 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.58437 |
| Gross Profits |
9,004,000,256 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00075999997 |
| Held Percent Institutions |
0.96005994 |
| Implied Shares Outstanding |
1,920,773,467 |
| Industry |
Household & Personal Products |
| Industry Disp |
Household & Personal Products |
| Industry Key |
household-personal-products |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,789,948,800 |
| Last Dividend Value |
0.21 |
| Last Fiscal Year End |
1,766,880,000 |
| Long Business Summary |
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey. |
| Long Name |
Kenvue Inc. |
| Market |
us_market |
| Market Cap |
34,112,937,984 |
| Market State |
POSTPOST |
| Max Age |
86,400 |
| Message Board Id |
finmb_1820759186 |
| Most Recent Quarter |
1,782,604,800 |
| Net Income To Common |
1,658,000,000 |
| Next Fiscal Year End |
1,798,416,000 |
| Non Diluted Market Cap |
33,940,067,161 |
| Number Of Analyst Opinions |
12 |
| Open |
17.91 |
| Operating Cashflow |
2,324,999,936 |
| Operating Margins |
0.19418 |
| Overall Risk |
5 |
| Payout Ratio |
0.96510005 |
| Peg Ratio |
1.42 |
| Phone |
908 874 1200 |
| Post Market Change |
-0.050001144 |
| Post Market Change Percent |
-0.28153798 |
| Post Market Price |
17.71 |
| Post Market Time |
1,791,935,569 |
| Previous Close |
17.83 |
| Price Eps Current Year |
15.021568 |
| Price Hint |
2 |
| Price To Book |
3.2314413 |
| Price To Sales Trailing12 Months |
2.2139757 |
| Profit Margins |
0.107609995 |
| Quick Ratio |
0.611 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.0699997 |
| Regular Market Change Percent |
-0.392595 |
| Regular Market Day High |
17.93 |
| Regular Market Day Low |
17.54 |
| Regular Market Day Range |
17.54 - 17.93 |
| Regular Market Open |
17.91 |
| Regular Market Previous Close |
17.83 |
| Regular Market Price |
17.76 |
| Regular Market Time |
1,791,921,602 |
| Regular Market Volume |
27,388,811 |
| Return On Assets |
0.06992 |
| Return On Equity |
0.15581 |
| Revenue Growth |
0.03 |
| Revenue Per Share |
8.035 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Consumer Defensive |
| Sector Disp |
Consumer Defensive |
| Sector Key |
consumer-defensive |
| Share Holder Rights Risk |
7 |
| Shares Outstanding |
1,920,773,467 |
| Shares Percent Shares Out |
0.03 |
| Shares Short |
57,664,722 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
72,137,384 |
| Short Name |
Kenvue Inc. |
| Short Percent Of Float |
0.0348 |
| Short Ratio |
2.18 |
| Source Interval |
15 |
| State |
NJ |
| Symbol |
KVUE |
| Target High Price |
23.0 |
| Target Low Price |
18.0 |
| Target Mean Price |
19.5 |
| Target Median Price |
19.0 |
| Total Cash |
1,110,000,000 |
| Total Cash Per Share |
0.578 |
| Total Debt |
8,613,000,192 |
| Total Revenue |
15,408,000,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.83 |
| Trailing Annual Dividend Yield |
0.04655076 |
| Trailing Eps |
0.86 |
| Trailing P E |
20.651163 |
| Trailing Peg Ratio |
1.4024 |
| Triggerable |
1 |
| Two Hundred Day Average |
18.0497 |
| Two Hundred Day Average Change |
-0.28969955 |
| Two Hundred Day Average Change Percent |
-0.016050104 |
| Type Disp |
Equity |
| Volume |
27,388,811 |
| Website |
https://www.kenvue.com |
| Zip |
7,901 |